What's happening
This bill allows pharmacists to administer only FDA-approved medications for mental health and substance use disorders under specific regulations.
Why it matters
Narrows the scope of what pharmacists can administer. by limiting them to only FDA-approved medications for mental health and substance use disorders, potentially increasing safety and oversight for patients.
Strengthens regulatory oversight. by requiring the Commissioner and Department of Health (and other agencies, as needed) to consult on the rules for pharmacist-administered injections, ensuring comprehensive and up-to-date standards.
Imposes stricter requirements for pharmacist training and patient consent. , including mandatory accredited education, competency maintenance, and clear protocols for patient privacy and emergency response, which could improve quality of care.
Requires direct communication and record-keeping with prescribers. , aiming to close the loop between pharmacists and doctors and enhance monitoring of patient outcomes and adverse reactions.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Let Pharmacists Give FDA Meds
Plain English, a few words. Used as the page title.
Sponsors
Senator · Senate District 46
No co-sponsors yet.
History
- Substituted by A608
- Ordered to third reading cal.62
- Referred to rules
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Let Pharmacists Give FDA Meds
Signed by Governor · Sponsor John T. McDonald III
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
853
2023-2024 Regular Sessions
IN SENATE
January 6, 2023
Introduced by Sen. BRESLIN -- read twice and ordered printed, and when printed to be committed to the Committee on Rules
AN ACT to amend the education law, in relation to medications approved by the U.S. Food and Drug Administration and administered by pharmacists
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Paragraph b of subdivision 22 of section 6802 of the education law, as added by a chapter of the laws of 2022 amending the education law relating to the definition of the practice of pharmacy, as proposed in legislative bills numbers S. 4870-B and A. 3040-B, is amended to read as follows:
b. The injection of medications into the deltoid muscle for the treatment of mental health and substance use disorder, as prescribed or ordered by a licensed prescriber, acting within the scope of their practice in this state and in accordance with regulations promulgated by the commissioner [and], in consultation with the department of health [in consultation with] and any other state agencies as necessary, [but not be limited to, providing] provided that:
(1) Such administration is conducted pursuant to a valid prescription or order that authorizes a pharmacist to administer medications approved by the U.S. Food and Drug Administration for the treatment of mental health and substance use disorder and the pharmacist notifies the licensed prescriber that the administration is complete. Administration in a pharmacy may not commence until after the patient has received the initial injection and is considered eligible for maintenance treatment by the licensed prescriber.
(2) Such prescription may be subject to reassessment at appropriate intervals, as determined by the licensed prescriber.
(3) Such activity is conducted in accordance with regulations, promulgated or adopted by the commissioner [and], in consultation with the
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD04183-01-3
department of health[, in consultation with] and any other state agencies, as necessary, which shall include requirements for the following:
(i) Training accredited by the accreditation council for pharmacy education, that may include educational experiences obtained through pharmacy school curricula, or a similar health authority or professional body appropriate for the medications being administered and their respective patient populations. Such training must be satisfactory to the commissioner and the department of health, in consultation with the board of pharmacy and any other state agencies, as necessary, which shall include, but not be limited to learning modules on techniques for administration by injections, indications, precautions, and contraindications in the use of agent or agents; record keeping and information; and handling emergencies, including anaphylaxis, needle-sticks and cardiopulmonary resuscitation.
(ii) Maintaining continued competency regarding the populations served and medications administered.
(iii) Pre-administration patient consent and education regarding common side effects, drug interactions, injection site reactions and other information routinely provided to patients upon dispensing. If a patient is unable to provide consent, the pharmacist must obtain consent from a person legally responsible when the recipient is incapable of consenting.
(iv) When administering an injection in a pharmacy, the pharmacist shall provide an area for the injection that provides for the patient's privacy.
(v) Record keeping and reporting of such administration by electronic transmission or facsimile to the patient's licensed prescriber, and, to the extent practicable, make himself or herself available to discuss the outcome of such injection, including any adverse reactions, with the licensed prescriber acting within their scope of practice.
(vi) Ensuring that only U.S. Food and Drug Administration approved medications are administered.
§ 2. This act shall take effect on the same date and in the same manner as a chapter of the laws of 2022 amending the education law relating to the definition of the practice of pharmacy, as proposed in legislative bills numbers S. 4870-B and A. 3040-B, takes effect.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the education law, in relation to medications approved by the U.S. Food and Drug Administration and administered by pharmacists
Purpose
This is a chapter amendment that makes changes to provisions of L.2022, c.802, to clarify provisions relating to regulatory authority and provisions related to medications that may be administered.
Summary of provisions
This legislation amends the underlying chapter to provide that SED will adopt regulations, in consultation with DOH and other necessary agen- cies, and clarifies that only medications approved by the U.S. Food and Drug Administration may be administered.
Justification
This legislation is a negotiated change to the underlying chapter.
Legislative history
Chapter amendment to chapter 802 of the Laws of 2022.
Fiscal implications
None.
Effective date
This act shall take effect on the same date and in the same manner as a chapter of the laws of 2022 amending the education law relating to the definition of the practice of pharmacy, as proposed in legislative bills numbers S.4870-B and A.3040-B, takes effect.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.